# FDA Warning Letter: Peak Performance Peptides
> 2026-09-01 · Center for Drug Evaluation and Research (CDER) · `9fbb6aef3adbbb22`
## Letter
- **Company:** Peak Performance Peptides
- **Posted Date:** 2026-09-01
- **Letter Issue Date:** 2026-08-24
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
Unapproved New Drugs/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*